Clinical Trial Update: Incidence and Severity of Residual Neuromuscular Blockade [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updating incidence and severity of residual neuromuscular blockade.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Residual Neuromuscular Blockade

Snippet

Sponsor: University of Washington | Conditions: Residual Neuromuscular Blockade | Phase 4 | Status: COMPLETED